2024
DOI: 10.1002/ps.7951
|View full text |Cite
|
Sign up to set email alerts
|

Workflows for detecting fungicide resistance in net form and spot form net blotch pathogens

Noel L. Knight,
Kul C. Adhikari,
Kejal N. Dodhia
et al.

Abstract: BACKGROUNDFungicide resistance in Pyrenophora teres f. maculata and P. teres f. teres has become an important disease management issue. Control of the associated barley foliar diseases, spot form and net form net blotch, respectively, relies on three major groups of fungicides, demethylation inhibitors (DMI), succinate dehydrogenase inhibitors (SDHI) and quinone outside inhibitors (QoI). However, resistance has been reported for the DMI and SDHI fungicides in Australia. To enhance detection of different resist… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(4 citation statements)
references
References 47 publications
0
4
0
Order By: Relevance
“…In Rehfus et al's [21] study, the field dose of fluxapyroxad showed stable control for P. teres isolates with mutations leading to B-H277Y, C-N75S, C-S135R, D-D124N, and D-D145G. Higher resistance factors have been associated with mutations C-G79R, D-H134R, D-D124E, and C-H134R, with reduced fluxapyroxad efficacy [21,35]. In Argentina, the detection of Ptt isolates carrying double mutation C-N75S + D-D145G raises concerns in fluxapyroxad field efficacy [36].…”
Section: Discussionmentioning
confidence: 97%
See 3 more Smart Citations
“…In Rehfus et al's [21] study, the field dose of fluxapyroxad showed stable control for P. teres isolates with mutations leading to B-H277Y, C-N75S, C-S135R, D-D124N, and D-D145G. Higher resistance factors have been associated with mutations C-G79R, D-H134R, D-D124E, and C-H134R, with reduced fluxapyroxad efficacy [21,35]. In Argentina, the detection of Ptt isolates carrying double mutation C-N75S + D-D145G raises concerns in fluxapyroxad field efficacy [36].…”
Section: Discussionmentioning
confidence: 97%
“…For further isolation, a QIAcube ® HT DNA extractor (Qiagen, Düsseldorf, Germany) and a DNeasy mericon 96 QIAcube HT Kit were used according to the manufacturer's instructions [37]. After DNA isolation, the Ptt isolates were confirmed with PCR and Sanger sequencing using ITS1 and ITS4 primers according to White et al [38] and a Ptt form-specific assay with primers according to Knight et al [35] (Table 1). PCR amplification was performed with a total volume of 20 µL mix consisting of 2 µL of 10× DreamTaq Green PCR buffer (Thermo Fisher Scientific, Waltham, MA, USA), 2 µL 10× GC-rich Enhancer (Solis BioDyne, Tartu, Estonia), 100 µM of each dNTP, 0.4 µM of specific forward and reverse primers (Table 1), 1 unit DreamTaq Hot Start DNA Polymerase (Thermo Fisher Scientific, Waltham, MA, United States), 10 ng of genomic DNA, and the remaining amount of MilliQ water (Merck KGaA, Darmstadt, Germany).…”
Section: Dna Extraction and Species Determinationmentioning
confidence: 99%
See 2 more Smart Citations